Related Experiment Video
Updated: Oct 11, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
SMAD4 mutations do not preclude epithelial-mesenchymal transition in colorectal cancer
Patrick Frey1,2,3, Antoine Devisme3,4, Katja Rose1
1Institute of Molecular Medicine and Cell Research, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Abstract:
Transforming growth factor beta (TGFβ) superfamily signaling is a prime inducer of epithelial-mesenchymal transitions (EMT) that foster cancer cell invasion and metastasis, a major cause of cancer-related deaths. Yet, TGFβ signaling is frequently inactivated in human tumor entities including colorectal cancer (CRC) and pancreatic adenocarcinoma (PAAD) with a high proportion of mutations incapacitating SMAD4, which codes for a transcription factor (TF) central to canonical TGFβ and bone morphogenetic protein (BMP) signaling. Beyond its role in initiating EMT, SMAD4 was reported to crucially contribute to subsequent gene regulatory events during EMT execution. It is therefore widely assumed that SMAD4-mutant (SMAD4mut) cancer cells are unable to undergo EMT. Here, we scrutinized this notion and probed for potential SMAD4-independent EMT execution using SMAD4mut CRC cell lines. We show that SMAD4mut cells exhibit morphological changes, become invasive, and regulate EMT marker genes upon induction of the EMT-TF SNAIL1. Furthermore, SNAIL1-induced EMT in SMAD4mut cells was found to be entirely independent of TGFβ/BMP receptor activity. Global assessment of the SNAIL1-dependent transcriptome confirmed the manifestation of an EMT gene regulatory program in SMAD4mut cells highly related to established EMT signatures. Finally, analyses of human tumor transcriptomes showed that SMAD4 mutations are not underrepresented in mesenchymal tumor samples and that expression patterns of EMT-associated genes are similar in SMAD4mut and SMAD4 wild-type (SMAD4wt) cases. Altogether, our findings suggest that alternative TFs take over the gene regulatory functions of SMAD4 downstream of EMT-TFs, arguing for considerable plasticity of gene regulatory networks operating in EMT execution. Further, they establish that EMT is not categorically precluded in SMAD4mut tumors, which is relevant for their diagnostic and therapeutic evaluation.
Insights
Cancer cells with SMAD4 mutations can still undergo epithelial-mesenchymal transitions (EMT) independently of TGFβ signaling. Alternative transcription factors compensate for SMAD4 loss, enabling invasion and metastasis in these tumors.
Area of Science:
- Cancer Biology
- Molecular Oncology
- Cellular Signaling
Background:
- Transforming growth factor beta (TGFβ) superfamily signaling drives epithelial-mesenchymal transitions (EMT), promoting cancer invasion and metastasis.
- SMAD4, a key transcription factor in TGFβ/BMP signaling, is frequently inactivated in cancers like colorectal cancer (CRC) and pancreatic adenocarcinoma (PAAD).
- It is widely assumed that SMAD4-mutant (SMAD4mut) cancer cells cannot undergo EMT due to SMAD4's crucial role in its execution.
Purpose of the Study:
- To investigate whether SMAD4-mutant cancer cells can execute EMT independently of TGFβ signaling.
- To explore the plasticity of gene regulatory networks in EMT execution.
- To determine the implications of SMAD4 mutations for EMT in human tumors.
Main Methods:
- Utilized SMAD4-mutant CRC cell lines to study EMT induction.
- Assessed morphological changes, invasiveness, and EMT marker gene expression upon SNAIL1 induction.
- Performed global transcriptome analysis to evaluate SNAIL1-dependent gene regulation.
- Analyzed human tumor transcriptomes to correlate SMAD4 mutations with EMT signatures.
Main Results:
- SMAD4mut cells exhibited EMT characteristics, including invasiveness and altered EMT marker gene expression, upon SNAIL1 induction.
- SNAIL1-induced EMT in SMAD4mut cells was independent of TGFβ/BMP receptor activity.
- Transcriptome analysis confirmed a robust EMT gene regulatory program in SMAD4mut cells.
- Human tumor data indicated that SMAD4 mutations are not underrepresented in mesenchymal tumors, with similar EMT gene expression patterns in SMAD4mut and SMAD4 wild-type (SMAD4wt) cases.
Conclusions:
- Alternative transcription factors can functionally replace SMAD4 downstream of EMT-inducing transcription factors, highlighting the plasticity of EMT regulatory networks.
- EMT is not entirely precluded in SMAD4-mutant tumors, challenging previous assumptions.
- These findings have significant implications for the diagnostic and therapeutic evaluation of SMAD4-mutant cancers.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

